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MaOBJECTIVES The aim of this study was to examine variation in outcomes for patients receiving carotid artery stenting
(CAS) across a sample of U.S. hospitals and assess the extent to which this variation was attributable to differences in
case mix and procedural volume.
BACKGROUND As CAS is increasingly being used throughout the United States, assessing hospital variation in CAS
outcomes is critical to understanding and improving the quality of care for patients with carotid artery disease.
METHODS Hospitals participating in the National Cardiovascular Data Registry–Carotid Artery Endarterectomy and
Revascularization Registry contributing more than 5 CAS procedures from 2005 through 2013 were eligible for inclusion.
We estimated unadjusted and risk-standardized rates of in-hospital stroke or death for each participating hospital using a
previously validated prediction model and applying hospital-level random effects.
RESULTS There were 188 hospitals contributing 19,381 CAS procedures during the period of interest. Unadjusted and risk-
standardized in-hospital strokeordeath rates ranged from0%to18.8%and1.2%to4.7%, respectively.Operator andhospital
volumes were not signiﬁcant predictors of outcomes after adjustment for case mix (p ¼ 0.15 and p ¼ 0.09, respectively).
CONCLUSIONS CAS outcomes vary 4-fold among hospitals, even after adjustment for differences in case mix.
Future work is needed to identify the sources of this variation and develop initiatives to improve patient outcomes.
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AB BR E V I A T I O N S
AND ACRONYM S
CAS = carotid artery stenting
S/D = in-hospital stroke or
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859R andomized trials have established the efﬁ-cacy of carotid artery stenting (CAS) in stan-dard- and high-surgical risk patients (1,2),
and this has resulted in increased use of this novel
therapy across the United States in recent years (3).
Understanding the impact that these changes in prac-
tice patterns have had on patient outcomes is critical
because the increased adoption of carotid endarterec-
tomy nearly 2 decades ago resulted in signiﬁcant vari-
ation in periprocedural stroke events (4).
CAS is a procedure with a well-established learning
curve (5) and is performed by providers from a variety
of medical specialties with patient selection practices
and technical expertise that may differ (6). For these
reasons, signiﬁcant variation in CAS outcomes might
be anticipated. Using the CARE (Carotid Artery
Revascularization and Endarterectomy) Registry, we
analyzed hospital-level variation in-hospital stroke or
death (S/D) rates and assessed the extent to which
this variation could be explained by differences in
patient case mix as well as differences in procedural
volume. Finding signiﬁcant variation across hospitals
could encourage further inquiry as to why such dif-
ferences exist and lead to the widespread dissemi-
nation of best practices that could improve care and
outcomes.
METHODS
STUDY COHORT. The CARE Registry includes pa-
tients receiving carotid revascularization with either
carotid endarterectomy or CAS. The Registry uses aFIGURE 1 Unadjusted and Risk-Standardized Rates of Stroke or Dea
Distribution of hospitals by unadjusted (A) and risk-standardized (B) ratstandardized dataset with written deﬁnitions
(7). Hospitals reporting more than 5 CAS
procedures from 2005 through 2013 were
eligible for inclusion. CAS procedures for
acute evolving stroke were excluded.CAS RISK MODEL. A CAS risk model predictive of S/D
was previously published and served as the basis
of risk adjustment used in this analysis (8). This
model was derived from 11,122 procedures performed
between 2005 and 2011 in the CARE Registry and was
internally validated by bootstrapping. Variables used
in this model were age, previous stroke, symptomatic
target lesion within 6 months, impending major sur-
gery, atrial ﬁbrillation, and no previous ipsilateral
carotid endarterectomy. To account for clustering
at the hospital level, model coefﬁcients were re-
estimated using a generalized linear model with
hospital-level random effects, as has been described
for other measures of hospital performance (9).
STATISTICAL ANALYSIS. Patient and hospital char-
acteristics are reported across low, average, and high
tertiles on the basis of hospital-level observed S/D
rates. Risk-standardized S/D rates were calculated for
each hospital. These values were deﬁned as the ratio
of the number of events predicted to have occurred at
a particular hospital to the expected number of
events at an “average” hospital with similar case mix,
multiplied by the mean unadjusted event rate for
all included hospitals (9). Predicted events were
estimated for each hospital using its own patient mix
and hospital-speciﬁc intercept; expected events were
deathth
es of stroke or death.
TABLE 1 Unadjusted Outcomes by Hospital Tertile
Outcome
Overall
(N ¼ 188)
Low
(n ¼ 62)
Average
(n ¼ 62)
High
(n ¼ 64) p Value
Stroke or death 451 (2.3) 0 (0) 182 (1.6) 269 (4.5) <0.001
Death 83 (0.4) 0 (0) 30 (0.3) 53 (0.9) <0.001
Stroke 401 (2.1) 0 (0) 164 (1.5) 237 (3.9) <0.001
Values are n (%).
TABLE 2 Procedural
Observed stroke or dea
Age, yrs*
Male
Body mass index, kg/m
Caucasian
Hypertension*
Dyslipidemia
Diabetes*
GFR <60 ml/min
Ischemic heart disease
MI within 6 weeks*
Impending major surge
History of heart failure
Atrial ﬁbrillation
Dementia
Previous ischemic strok
Previous ipsilateral CAS
Previous ipsilateral CEA
Symptomatic target les
Pre-procedure imaging
Carotid duplex
Magnetic resonance
Computed tomograp
Type III aortic arch
Visible thrombus prese
Ulceration
Lesion length, mm
Percent of stenosis
Embolic protection att
Values are n (%) or mean
CAS ¼ carotid artery s
myocardial infarction.
Hawkins et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 6 , 2 0 1 5
CAS Variation M A Y 2 0 1 5 : 8 5 8 – 6 3
860estimated using each individual hospital’s case mix
and average hospital intercept for all facilities
included in this analysis. We estimated 95% con-
ﬁdence intervals using hospital-based bootstrap
resampling (10).
To examine the impact that risk adjustment had on
hospital performance, we quantiﬁed the percent
of hospitals that were reclassiﬁed into different per-
formance tertiles after risk adjustment. We also
calculated the median odds ratio as a measure of
between-hospital variation in outcomes (11). Finally,Characteristics by Tertile of Observed Stroke or Death Rates
Low
(n ¼ 2,259)
Average
(n ¼ 11,082)
High
(n ¼ 6,040) p Value
th rate 0 (0) 182 (1.6) 269 (4.5) <0.001
70.9  10.4 70.6  10.2 70.8  10.5 0.22
1,382 (61.2) 6,947 (62.7) 3,624 (60.0) 0.002
2* 29.6  17.1 29.5  17.2 29.1  16.8 0.30
2,072 (91.7) 10,252 (92.5) 5,478 (90.7) <0.001
2,040 (90.4) 10,056 (90.9) 5,471 (90.7) 0.74
1,913 (84.8) 9,822 (88.8) 5,128 (85.0) <0.001
876 (38.8) 4,178 (37.8) 2,254 (37.4) 0.48
877 (40.7) 4,031 (37.3) 2,174 (37.4) 0.01
1,222 (54.3) 6,219 (56.3) 3,091 (51.2) <0.001
56 (2.5) 291 (2.6) 140 (2.3) 0.46
ry* 76 (3.4) 387 (3.5) 218 (3.6) 0.85
444 (19.7) 1,744 (15.8) 1,098 (18.2) <0.001
315 (14.0) 1,354 (12.3) 806 (13.4) 0.03
88 (3.9) 279 (2.5) 255 (4.2) <0.001
e 359 (15.9) 1,567 (14.1) 1,123 (18.6) <0.001
* 75 (3.3) 374 (3.4) 214 (3.5) 0.81
438 (19.4) 1,690 (15.2) 1,105 (18.3) <0.001
ion 979 (43.4) 4,418 (40.0) 2,758 (45.8) <0.001
1,431 (64.3) 7,323 (66.6) 3,803 (63.3) 0.02
imaging 206 (9.5) 1,207 (11.0) 770 (12.9) <0.001
hy 666 (30.3) 3,076 (28.1) 1,891 (31.6) 0.01
216 (10.3) 987 (10.0) 552 (10.0) 0.001
nt 100 (4.5) 335 (3.1) 232 (3.9) <0.001
574 (25.8) 2,739 (25.3) 1,871 (31.4) <0.001
21.1  11.6 19.8  9.9 19.5  11.4 <0.001
83.6  11.5 84.7  10.9 83.6  11.4 <0.001
empted 2,124 (94.5) 10,781 (97.4) 5,788 (95.9) <0.001
 SD. *All p values are <0.05 except where denoted by asterisk.
tenting; CEA ¼ carotid endarterectomy; GFR ¼ glomerular ﬁltration rate; MI ¼annual operator and hospital volume were each
separately introduced into the hierarchical model
before and after adjusting for case mix to determine
whether these variables affected risk-standardized
S/D rates. All statistical analyses were performed
using SAS version 9.2 (SAS Institute, Cary, North
Carolina).
RESULTS
HOSPITAL-LEVEL VARIATION. There were 19,381
procedures from 188 hospitals included in this anal-
ysis. The dataset was very complete; <1% of each risk
model variable had missing values. The mean unad-
justed S/D rate across the entire cohort was 2.4%.
Wide variation in procedural outcomes was present,
with S/D rates ranging from 0% to 18.8% (Figure 1A).
Corresponding 25th, 50th, and 75th percentile rates
were 0%, 1.8%, and 3.7%, respectively. Individual
components of the composite endpoint are shown in
Table 1.
CHARACTERISTICS BY TERTILE. Hospitals were
divided into low, average, and high tertiles on the basis
of corresponding observed S/D rates (<0.3%, 0.3 to
3.1%, or >3.1%, respectively). Procedural characteris-
tics of these tertiles are displayed in Tables 2 and 3.
RISK-STANDARDIZED S/D RATES. After adjusting for
case mix, S/D rates ranged from 1.2% to 4.7%
(Figure 1B). Low tertile hospitals had adjusted S/D
rates of 1.2% to 2.2% compared with 2.5% to 4.7% in
high tertile facilities. Corresponding 25th, 50th, and
75th percentile adjusted rates were 2.1%, 2.3%, and
2.7%, respectively. A plot of individual hospital rates
was also constructed (Figure 2).
Overall, 63 hospitals (34%) shifted to different
tertiles of performance after risk adjustment
(Figure 3). Of the 62 hospitals in the unadjusted low
tertile group, 37 (60%) remained in the low tertile
group, but 25 (40%) shifted to the average group.
In the unadjusted average tertile group, 6 (10%)
shifted to the high tertile group, and 25 moved to the
low tertile group (25%). In the unadjusted high tertile
group, 7 (11%) shifted to the average tertile group,
whereas the rest (n ¼ 57, 89%) remained in the
highest tertile group.
The median odds ratio was calculated to be 1.51
(95% conﬁdence interval: 1.28 to 1.71), meaning that
there was, on average, a 50% difference in the odds
of experiencing S/D between 2 randomly selected
hospitals treating the identical patient. Operator
volume and hospital volume were not found to be
signiﬁcant predictors of outcomes after adjustment in
case mix (p ¼ 0.15 and p ¼ 0.09, respectively).
TABLE 3 Hospital Characteristics by Tertile of Observed Stroke or Death Rates
Low
(n ¼ 62)
Average
(n ¼ 62)
High
(n ¼ 64) p Value
Observed stroke or death rate, % 0 (0) 182 (1.6) 269 (4.5) <0.001
Annual procedural volume
per hospital
11.3 (7.2–17.1) 25.7 (14.7–39.5) 17.7 (9.0–29.1) <0.001
Hospital region 0.06
New England 1 (1.6) 3 (4.8) 2 (3.1)
Mid Atlantic 9 (14.5) 10 (16.1) 3 (4.7)
South Atlantic 9 (14.5) 16 (25.8) 14 (21.9)
East North Central 7 (11.3) 13 (21.0) 17 (26.6)
East South Central 4 (6.5) 3 (4.8) 7 (10.9)
West North Central 4 (6.5) 2 (3.2) 7 (10.9)
West South Central 15 (24.2) 8 (12.9) 4 (6.3)
Mountain 5 (8.1) 1 (1.6) 4 (6.3)
Paciﬁc 8 (12.9) 6 (9.7) 6 (9.4)
Hospital type 0.09
Rural 15 (24.2) 11 (17.7) 4 (6.3)
Suburban 21 (33.9) 24 (38.7) 26 (40.6)
Urban 26 (41.9) 27 (43.5) 34 (53.1)
Teaching 25 (40.3) 29 (46.8) 28 (43.8) 0.77
Values are n (%) or mean (interquartile range).
FIGURE 2 Plot of Individual Hospitals (x-axis) and Their Associated Inhospital Stroke
or Death Rates (y-axis)
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861DISCUSSION
In an analysis of 188 hospitals performing CAS in the
United States as part of a large national registry, we
found in-hospital outcomes vary 4-fold, and the odds
of experiencing stroke or death differs by w50%
(mean odds ratio: 1.51) for 2 randomly selected facil-
ities treating an identical patient. These data suggest
that substantial quality differences may exist among
U.S. hospitals that offer CAS.
CAS QUALITY ASSESSMENT. The risk-standardized
S/D metric developed here is valid, reliable, clini-
cally meaningful, and feasible to implement in clinical
practice. This measure should allow institutions and
clinicians to benchmark their performance against
others and, through the identiﬁcation of best prac-
tices, has the potential to engender policies aimed at
quality improvement. Outcomes assessment is but 1
component of quantifying health care quality, how-
ever, and additional work examining structure and
process elements for carotid revascularization is
needed to develop additional quality measures (12).
Potential measures could include the development of
uniform credentialing requirements for CAS operators
or additional procedural metrics such as embolic
protection device use, procedural times, and medi-
cation use (e.g., thienopyridine pre-loading, statins).
Epstein et al. (13) recently reported risk-adjusted
30-day mortality rates for 22,708 CAS procedures
performed in 927 U.S. hospitals from 2009 through
2011. They found that mortality rates vary nearly
5-fold (1.1% to 5.1%) in Medicare beneﬁciaries
receiving CAS, although only 13 hospitals (1.4% of the
cohort) were classiﬁed as poor outliers on the basis of
having 95% conﬁdence intervals that excluded the
national mean. The ﬁndings of our analysis, which are
augmented with important clinical data and risk
adjustment, are similar, demonstrating a 4-fold vari-
ation in S/D rates and <2% of facilities being identi-
ﬁed as outliers using similar methods (data not
shown). The potential advantages of our analysis are
that it includes stroke in the composite endpoint,
accounts for crucial patient characteristics that affect
CAS outcomes (e.g., symptomatic status), and may be
less vulnerable to coding and reporting errors.
PROCEDURAL VOLUME CONSIDERATIONS. Low CAS
volumes have an important implication when quanti-
fying hospital performance. The generation of risk-
adjusted event rates for low-volume procedures
inherently results in wide 95% conﬁdence intervals,
the boundaries of which have been traditionally used
to identify outliers (10). In this scenario, the result is
that the majority of facilities are found to perform“as expected”—the discriminatory capacity of a
risk-adjusted outcome measure is diminished. In our
analysis, only a small minority of such hospitals were
identiﬁed as outliers using this methodology (<2%,
data not shown).
FIGURE 3 Shifts in Hospital Performance by Tertile After Risk Standardization
The y-axis stratiﬁes hospitals into low, average, and high tertiles before risk adjustment.
The x-axis displays the shift in performance that occurs after risk adjustment.
PERSPECTIVES
WHAT IS KNOWN? CAS is a relatively new proce-
dure that has become widely used across the United
States in recent years. It is not well established
whether signiﬁcant variation in outcomes exists
among facilities performing CAS.
WHAT IS NEW? Rates of in-hospital stroke or death
vary nearly 4-fold among hospitals participating in a
large national CAS registry, even after adjusting for
differences in case mix.
WHAT IS NEXT? Future work is needed to identify
the sources of this variation and develop initiatives to
improve patient outcomes.
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862Similar difﬁculties have been reported elsewhere.
Dimick et al. (14) examined 7 surgical procedures for
which risk-adjusted mortality was advocated as a
quality measure. For coronary artery bypass grafting,
the mean mortality rate was found to be 3.5%, and a
minimal caseload of 219 procedures was needed to
detect facilities with a mortality rate twice that of the
national average. Only 61% of hospitals providing
coronary artery bypass grafting met this volume by
1 year. For hip replacement, with a mortality risk
of <1%, nearly 2,700 procedures would be required to
detect a doubling of the mortality rate, a volume
achieved in <1% of hospitals even when pooling
procedures over 5 years.
SOURCES OF CAS VARIATION. In our analysis, pro-
cedural volume was not found to be an important
predictor of outcomes after adjustment in case mix.
This stands in contrast to previous reports that
demonstrated an association between volume and
CAS outcomes (5). There are several potential expla-
nations for our ﬁndings. Therapeutic advances (e.g.,
embolic protection) and improved patient selection
have resulted in steady improvement in CAS out-
comes in recent years (15). These changes may have
mitigated the association between volume and
outcomes, particularly because our analysis included
procedures from a more modern time period com-
pared with previous reports. Our analysis was also
limited to centers participating in a voluntary registry
aimed at quality assessment and improvement. As
such, the hospital participants may have morecomprehensive measures in place to promote patient
safety, or they may use more rigorous credentialing
standards for providers performing CAS in their in-
stitutions. Finally, our sample size may not have been
large enough to identify a statistically signiﬁcant as-
sociation between volume and outcomes.
STUDY LIMITATIONS. The generalizability of our
ﬁndings to non-CARE facilities may be limited as this
is a voluntary registry in which participants may be
more prone to quality assessment and improvement.
Our analysis examined in-hospital events only; it is
uncertain whether examining 30-day outcomes would
have resulted in different ﬁndings. Our timeframe was
broad and included a large number of diverse facil-
ities. It is possible that patient selection practices for
CAS may have varied among these institutions, and it
is unclear whether examining a narrower, more recent
period would have resulted in less observed variation.
Finally, despite rigorous risk adjustment, we cannot
exclude the possibility that unmeasured confounders
may have inﬂuenced our results.
CONCLUSIONS
Using risk-standardized S/D rates, we identiﬁed sig-
niﬁcant variation in outcomes for hospitals partici-
pating in a national CAS registry. Future work is
needed to identify additional sources of this variation
and to develop initiatives to improve the quality of
care for patients receiving CAS.
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